Online citations, reference lists, and bibliographies.

Use Of Active Surveillance Or Watchful Waiting For Low-Risk Prostate Cancer And Management Trends Across Risk Groups In The United States, 2010-2015

Brandon A Mahal, Santino S Butler, Idalid Franco, Daniel E. Spratt, Timothy R. Rebbeck, Anthony V. D'Amico, Paul Linh Nguyen
Published 2019 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references



This paper is referenced by
10.1371/journal.pone.0224151
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)
Michela Buglione (2019)
10.1001/jamanetworkopen.2019.19284
Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years
Evan Kovac (2020)
10.1177/1073274820902267
Geographic-Level Association of Contemporary Changes in Localized and Metastatic Prostate Cancer Incidence in the Era of Decreasing PSA Screening
Daniel X Yang (2020)
10.1080/13685538.2020.1772227
Hematologic parameters are not predictors of upgrading or treatment in a racially diverse prospective study of men with prostate cancer on active surveillance.
Thomas M. Shelton (2020)
10.1002/cncr.32605
Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.
Shreyas S Joshi (2019)
10.1038/s41391-019-0175-9
United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015
Santino S Butler (2019)
10.1001/jamanetworkopen.2019.11019
Magnetic Resonance Imaging–Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer
Rajiv Jayadevan* (2019)
10.1016/j.urolonc.2019.09.015
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis.
Sophie Knipper (2019)
10.1002/cncr.32557
Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts.
Jane M Lange (2019)
Est-ce l’âge d’arrêter?: Dépistage approprié chez les patients âgés
Roland M. Grad (2019)
10.1002/cncr.32456
Proton-beam therapy after radical prostatectomy: Continued DVH idolatry?
W Robert Lee (2019)
10.1016/J.EUO.2019.04.006
Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016.
Wee Loon Ong (2019)
10.1001/jamaoncol.2020.0109
Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer.
Robert T Dess (2020)
10.1155/2020/8517130
Prognostic Factors for Overall Survival of Patients with Prostate Cancer in Kyadondo County, Uganda
James Joseph Yahaya (2020)
Age to stop? Appropriate screening in older patients.
Roland M. Grad (2019)
10.1016/j.eururo.2020.01.009
The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations.
Chang Wook Jeong (2020)
10.1111/bju.14846
Dr. Google: Trends in Online Interest in Prostate Cancer Screening, Diagnosis and Treatment.
Michael E Rezaee (2019)
10.3322/caac.21565
Cancer treatment and survivorship statistics, 2019.
Kimberly D Miller (2019)
10.1016/j.urology.2019.12.007
Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States.
Bashir Al Hussein Al Awamlh (2020)
10.1186/s12911-020-1081-8
Development of a patient decision aid for the management of superficial basal cell carcinoma (BCC) in adults with a limited life expectancy
Alexandra Junn (2020)
10.1007/s00345-020-03298-6
National trends in the management of patients with positive surgical margins at radical prostatectomy
Kamyar Ghabili (2020)
10.1111/bju.14900
Comparison of outcomes in salvage robotic-assisted laparoscopic prostatectomy for post-primary radiation vs. Focal therapy.
Fikret Onol (2019)
10.1016/j.eururo.2019.04.033
Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.
Giorgio Gandaglia (2019)
10.1038/s41379-020-0551-y
Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies
Patricia Raciti (2020)
10.1007/s00120-020-01123-x
Die nichtinvasive Therapie des organbegrenzten Prostatakarzinoms im Alter – Ergebnisse der HAROW-Studie
Jan Herden (2020)
10.1038/s41391-020-0226-2
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Jeffrey J. Tosoian (2020)
10.1016/j.eururo.2019.04.027
Re: Active Surveillance of Prostate Cancer is a Viable Option in Men Younger than 60 Years.
Nazareno Suardi (2019)
10.1158/1055-9965.EPI-19-0412
Cancer Progress and Priorities: Prostate Cancer
Kevin H Kensler (2020)
Semantic Scholar Logo Some data provided by SemanticScholar